Written Question · S7W-01831 · Session 7
What action it is taking to address concerns of a so-called postcode lottery in access to genomic testing for breast cancer patients, and w…
The question
To ask the Scottish Government what action it is taking to address concerns of a so-called postcode lottery in access to genomic testing for breast cancer patients, and whether this includes accelerating the evaluation of multigene assays through Healthcare Improvement Scotland and the Scottish Health Technologies Group.
The answer
The standards of care for cancer treatment are rightly developed independently of Scottish Government by those with the relevant clinical expertise.The NHS Scotland Cancer Collaborative’s Clinical Management Pathways (CMPs) define national standards of care for cancer treatment. The CMP for breast cancer has incorporated the Scottish Health Technologies Group (SHTG) Council’s 2023 independent recommendation on the use of commercial multigene assays for breast cancer patients across Scotland. SHTG have criteria and processes in place to judge whether new evidence is sufficient to revise its existing recommendations of these commercial tests. NHS genomic testing, delivered within our laboratory service, is nationally commissioned by NHS National Services Division to ensure equitable access across Scotland.
In the Official Report
No contribution in the Official Report cites S7W-01831 by reference.